Role of caspases in murine limb bud cell death induced by 4-hydroperoxycyclophosphamide, an activated analog of cyclophosphamide

Teratology

Volumn 66, Issue 6, 2002, Pages 288-299

  Huang, Chunwei ^a   Hales, Barbara F ^a  

^a MCGILL UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

4 HYDROPEROXYCYCLOPHOSPHAMIDE; CASPASE; CASPASE 3; CASPASE 8; CASPASE 9; CYCLOPHOSPHAMIDE DERIVATIVE; FAS ANTIGEN; FAS LIGAND;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL DEATH; CONTROLLED STUDY; EMBRYO; ENZYME ACTIVATION; ENZYME ACTIVITY; IMMUNOHISTOCHEMISTRY; LIMB BUD; LIMB DEVELOPMENT; LIMB MALFORMATION; MOUSE; NICK END LABELING; NONHUMAN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; WESTERN BLOTTING;

ANIMALS; APOPTOSIS; CASPASE 3; CASPASE 8; CASPASE 9; CASPASES; CYCLOPHOSPHAMIDE; ENZYME PRECURSORS; EXTREMITIES; FEMALE; IMMUNOHISTOCHEMISTRY; LIMB BUD; LIMB DEFORMITIES, CONGENITAL; MICE; TERATOGENS;

MURINAE;

EID: 0036912334     PISSN: 00403709     EISSN: None     Source Type: Journal    
DOI: 10.1002/tera.10100     Document Type: Article

References (56)

1. Ashkenazi A, Dixit VM. 1998. Death receptors: Signaling and modulation. Science 281:1305-1308.
2. Alles AJ, Sulik KK. 1989. Retinoic-acid-induced limb-reduction defects: Perturbation of zones of programmed cell death as a pathogenetic mechanism. Teratology 40:163-171.
3. Aravind L, Dixit VM, Koonin EV. 2001. Apoptotic molecular machinery: Vastly increased complexity in vertebrates revealed by genome comparisons. Science 291:1279-1284.
4. Boldin MP, Goncharov TM, Goltsev YV, Wallach D. 1996. Involvement of MACH, a novel MORT1/FADD-interacting protease, in Fas/APO-1- and TNF receptor-induced cell death. Cell 85:803-815.
5. Budihardjo I, Oliver H, Lutter M, Luo X, Wang X. 1999. Biochemical pathways of caspase activation during apoptosis. Annu Rev Cell Dev Biol 15:269-290.
6. Cecconi F, Alvarez-Bolado G, Meyer BI, Roth KA, Gruss P. 1998. Apaf1 (CED-4 homolog) regulates programmed cell death in mammalian development. Cell 94:727-737.
7. Chautan M, Chazal G, Cecconi F, Gruss P, Golstein P. 1999. Interdigital cell death can occur through a necrotic and caspase-independent pathway. Curr Biol 9:967-970.
8. Chen S, Guttridge DC, Tang E, Shi S, Guan K, Wang CY. 2001. Suppression of tumor necrosis factor-mediated apoptosis by nuclear factor κB-independent bone morphogenetic protein/Smad signaling. J Biol Chem 276:39259-39263.
9. Francis-West P, Tickle C. 1996. Limb development. Curr Top Microbiol Immunol, 212:239-259.
10. Fujita E, Egashira J, Urase K, Kuida K, Momoi T. 2001. Caspase-9 processing by caspase-3 via a feedback amplification loop in vivo. Cell Death Differ 8:335-344.
11. Gibson JE, Becker BA. 1968. The teratogenicity of cyclophosphamide in mice. Cancer Res 28:475-480.
12. Glucksmann A. 1951. Cell death in normal vertebrate ontogeny. Biol Rev 26:59-86.
13. Garcia-Calvo M, Peterson EP, Leiting B, Ruel R, Nicholson DW, Thornberry NA. 1998. Inhibition of human caspases by peptide-based and macromolecular inhibitors. J Biol Chem 273:32608-32613.
14. Green D, Kroemer G. 1998. The central executioners of apoptosis: Caspases or mitochondria? Trends Cell Biol 8:267-271.
15. Jacobsen MD, Weil M, Raff MC. 1996. Role of Ced-3/ICE-family proteases in staurosporine-induced programmed cell death. J Cell Biol 33:1041-1051.
16. Jacobson MD, Weil M, Raff MC. 1997. Programmed cell death in animal development. Cell 88:347-354.
17. Johnson DE. 2000. Noncaspase proteases in apoptosis. Leukemia 14:1695-1703.
18. Johnson RL, Tabin CJ. 1997. Molecular models for vertebrate limb development. Cell 90:979-990.
19. Joza N, Susin SA, Daugas E, Stanford WL, Cho SK, Li CY, Sasaki T, Elia AJ, Cheng HY, Ravagnan L, Ferri KF, Zamzami N, Wakeham A, Hakem R, Yoshida H, Kong YY, Mak TW, Zuniga-Pflucker JC, Kroemer G, Penninger JM. 2001. Essential role of the mitochondrial apoptosis-inducing factor in programmed cell death. Nature 410:549-554.
20. Kitamura K, Minami Y, Yamamoto K, Akao Y, Kiyoi H, Saito H, Naoe T. 2000. Involvement of CD95-independent caspase 8 activation in arsenic trioxide-induced apoptosis. Leukemia 14:1743-1750.
21. Kwasigroch TE, Skalko RG, Church JK. 1984. Mouse limb bud development in submerged culture: Quantitative assessment of the effects of in vivo exposure to retinoic acid. Teratog Carcinog Mutagen 4:311-326.
22. Kuida K, Haydar TF, Kuan CY, Gu Y, Taya C, Karasuyama H, Su MS, Rakic P, Flavell RA. 1998. Reduced apoptosis and cytochrome mediated caspase activation in mice lacking caspase 9. Cell 94:325-337.
23. Kuida K, Zheng TS, Na S, Kuan C, Yang D, Karasuyama H, Rakic P, Flavell RA. 1996. Decreased apoptosis in the brain and premature lethality in CPP32-deficient mice. Nature 384:368-372.
24. Leist M, Jäätelä M. 2001. Four deaths and a funeral: From caspases to alternative mechanisms. Nat Rev Mol Cell Biol 2:589-598.
25. Li L, Prevette D, Oppenheim RW, Milligan CE. 1998. Involvement of specific caspases in motoneuron cell death in vivo and in vitro after trophic factor deprivation. Mol Cell Neurosci 12:157-167.
26. Li P, Nijhawan D, Budihardjo I, Srinivasula SM, Ahmad M, Alnemri ES, Wang X. 1997. Cytochrome c and dATP-dependent formation of Apaf-1/caspase-9 complex initiates an apoptotic protease cascade. Cell 91:479-489.
27. Lindsten T, Ross AJ, King A, Zong WX, Rathmell JC, Shiels HA, Ulrich E, Waymire KG, Mahar P, Frauwirth K, Chen Y, Wei M, Eng VM, Adelman DM, Simon MC, Ma A, Golden JA, Evan G, Korsmeyer SJ, MacGregor GR, Thompson CB. 2000. The combined functions of proapoptotic Bcl-2 family members bak and bax are essential for normal development of multiple tissues. Mol Cell 6:1389-1399.
28. Little SA, Mirkes PE 2002. Teratogen-induced activation of caspase 9 and the mitochondrial apoptotic pathway in early postimplantation mouse embryos. Toxicol Appl Pharmacol 181:142-151.
29. Milligan CE, Prevette D, Yaginuma H, Homma S, Cardwell C, Fritz LC, Tomaselli KJ, Oppenheim RW, Schwartz LM. 1995. Peptide inhibitors of the ICE protease family arrest programmed cell death of motoneurons in vivo and in vitro. Neuron 15:385-393.
30. Milligan CE, Schwartz LM. 1997. Programmed cell death during animal development. Brit Med Bull 52:570-590.
31. Mirkes PE. 1985. Cyclophosphamide teratogenesis: A review. Teratog Carcinog Mutagen 5:75-88.
32. Mirkes PE. 2002. 2001 Warkany Lecture: To die or not to die, the role of apoptosis in normal and abnormal mammalian development. Teratology 65:228-239.
33. Miura M, Zhu H, Rotello R, Hartwieg EA, Yuan J. 1993. Induction of apoptosis in fibroblasts by IL-1 beta-converting enzyme, a mammalian homolog of the C. elegans cell death gene ced-3. Cell 75:653-660.
34. Moallem SA, Hales BF. 1995. The induction of apoptosis and cathepsin D in limbs exposed in vitro to an activated analog of cyclophosphamide. Teratology 52:3-14.
35. Moallem SA, Hales BF. 1996. Transglutaminase and clusterin induction during normal and abnormal limb development in the mouse. Biol Reprod 55:281-290.
36. Moallem SA, Hales BF. 1998. The role of p53 and cell death by apoptosis and necrosis in 4-hydroperoxycyclophosphamide-induced limb malformations. Development 125:3225-3234.
37. Muzio M, Chinnaiyan AM, Kischkel FC, O'Rourke K, Shevchenko A, Ni J, Scaffidi C, Bretz JD, Zhang M, Gentz R, Mann M, Krammer PH, Peter ME, Dixit VM. 1996. FLICE, a novel FADD-homologous ICE/CED-3-like protease, is recruited to the CD95 (Fas/APO-1) death-inducing signaling complex. Cell 85:817-827.
38. Nakamura N, Fujioka M, Mori C. 2000. Alteration of programmed cell death and gene expression by 5-bromodeoxyuridine during limb development in mice. Toxicol Appl Pharmacol 167:100-106.
39. Nakanishi K, Maruyama M, Shibata T, Morishima N. 2001. Identification of a caspase-9 substrate and detection of its cleavage in programmed cell death during mouse development. J Biol Chem 276:41237-41244.
40. Neubert D, Barrach H-J. 1977. Techniques applicable to study morphogenetic differentiation of limb buds in organ culture. In: Neubert D, Merker H-J, Kwasigroch TE, editors. Methods in Prenatal Toxicology. Massachusetts: PSG Publishing Co. Inc. p. 241-251.
41. Plesnila N, Zinkel S, Le DA, Amin-Hanjani S, Wu Y, Qiu J, Chiarugi A, Thomas SS, Kohane DS, Korsmeyer SJ, Moskowitz MA. 2001. BID mediates neuronal cell death after oxygen/glucose deprivation and focal cerebral ischemia. Proc Natl Acad Sci USA 98:15318-15323.
42. Saunders JW. 1966. Death in embryonic systems. Science 154:604-612.
43. Schwartz PS, Waxman DJ. 2001. Cyclophosphamide induces caspase 9-dependent apoptosis in 9L tumor cells. Mol Pharmacol 60:1268-1279.
44. Sperandio S, de Belle I, Bredesen DE. 2000. An alternate, nonapoptotic form of programmed cell death. Proc Nat Acad Sci USA 7:14376-14381.
45. Studier FW. 1973. Analysis of T7 early RNAs and proteins on slab gels. J Mol Biol 79:237-248.
46. Sun XM, MacFarlane M, Zhuang J, Wolf BB, Green DR, Cohen GM. 1999. Distinct caspase cascades are initiated in receptor-mediated and chemical-induced apoptosis. J Biol Chem 274:5053-5060.
47. Towbin H, Staehelin T, Gordon J. 1979. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: Procedure and some applications. Proc Natl Acad Sci USA 76:4350-4354.
48. Umpierre CC, Little SA, Mirkes PE. 2001. Co-localization of active caspase-3 and DNA fragmentation (TUNEL) in normal and hyperthermia-induced abnormal mouse development. Teratology 63:134-143.
49. Varfolomeev EE, Schuchmann M, Luria V, Chiannilkulchai N, Beckmann JS, Mett IL, Rebrikov D, Brodianski VM, Kemper OC, Kollet O, Lapidot T, Soffer D, Sobe T, Avraham KB, Goncharov T, Holtmann H, Lonai P, Wallach D. 1998. Targeted disruption of the mouse caspase 8 gene ablates cell death induction by the TNF receptors, Fas/Apo1, and DR3 and is lethal prenatally. Immunity 9:267-276.
50. Vaux DL, Korsmeyer SJ. 1999. Cell death in development. Cell 96:245-254.
51. Weil M, Jacobson MD, Coles HS, Davies TJ, Gardner RL, Raff KD, Raff MC. 1996. Constitutive expression of the machinery for programmed cell death. J Cell Biol 133:1053-1059.
52. Weil M, Jacobson MD, Raff MC. 1997. Is programmed cell death required for neural tube closure? Curr Biol 7:281-284.
53. Woo M, Hakem R, Soengas MS, Duncan GS, Shahinian A, Kagi D, Hakem A, McCurrach M, Khoo W, Kaufman SA, Senaldi G, Howard T, Lowe SW, Mak TW. 1998. Essential contribution of caspase 3/CPP32 to apoptosis and its associated nuclear changes. Genes Dev 12:806-819.
54. Yoshida H, Kong YY, Yoshida R, Elia AJ, Hakem A, Hakem R, Penninger JM, Mak TW. 1998. Apaf1 is required for mitochondrial pathways of apoptosis and brain development. Cell 94:739-750.
55. Zakeri ZF, Ahuja HS. 1997. Cell death/apoptosis: Normal, chemically induced, and teratogenic effect. Mutat Res 396:149-161.
56. Zou H, Henzel WJ, Liu X, Lutschg A, Wang X. 1997. Apaf-1, a human protein homologous to C. elegans CED-4, participates in cytochrome c-dependent activation of caspase-3. Cell 90:405-413.